Andrew Trask litigates disputes involving intellectual property and technology.  He has represented clients in the U.S. district courts, on appeal, in inter partes review proceedings, and in commercial arbitrations.  With a doctorate in physical chemistry, work experience in Silicon Valley, and a handful of patents to his name, Andrew enjoys learning complex subjects and simplifying them for lay audiences.  His cases have involved pharmaceutical and biotech products, mobile apps and hardware, search and video algorithms, wearable devices, and medical technologies.

Patent appeals are a focus of Andrew’s practice.  He has briefed and argued several cases before the U.S. Court of Appeals for the Federal Circuit, recently obtaining a unanimous reversal of an adverse agency decision in Google LLC v. Koninklijke Philips N.V.* In 2021, Andrew was elected to the Federal Circuit Bar Association’s Board of Directors, and he also serves as the current Chair of the FCBA Rules Committee. Andrew teaches Federal Circuit Practice as an Adjunct Professor at George Mason University School of Law.

Andrew focuses his pro bono practice on appeals to the U.S. Court of Appeals for Veterans Claims, helping military veterans obtain benefits for service-related medical disabilities.  He also serves as a Board member of CulinaryCorps, America’s first service-related nonprofit organization for culinary professionals.

Andrew joined the firm following a clerkship with the Honorable Alan D. Lourie of the Federal Circuit.  He left the firm to serve as in-house litigation counsel at a major technology company, then returned and joined the firm’s partnership in 2021.  The first lawyer in his family, Andrew attended Fordham Law School as an evening student.  He graduated magna cum laude as a member of the Order of the Coif and an Associate Editor of the Fordham Law Review, while working full-time at Jones Day prosecuting patent applications involving pharmaceutical and biotech inventions.  Prior to law school, Andrew served as a scientist at Pfizer and earned his Ph.D. from the University of Cambridge, where he received the Lowry Prize for the top departmental graduate seminar.

* All cases vary and none is predictive.


  • Conditional Cross-Appeals at the Federal Circuit, 22 FED. CIR. B.J. 501 (2013).
  • “Obvious to Try”: A Proper Patentability Standard in the Pharmaceutical Arts?, 76 FORDHAM L. REV. 2625 (2008).
  • An Overview of Pharmaceutical Cocrystals as Intellectual Property, 4 MOLECULAR PHARMACEUTICS 301 (2007).
  • Pharmaceutical Cocrystals: A Molecular Materials Approach to Physical Property Enhancement, 31 MRS BULL. 875 (2006) (co-author).
  • Solid-State Acid-Base Interactions in Complexes of Heterocyclic Bases and Dicarboxylic Acids, 128 J. AM. CHEMICAL SOC’Y, 8199 (2006) (co-author).
  • Screening for Inclusion Compounds and Systematic Construction of Three-Component Solids via Liquid-Assisted Grinding, 45 ANGEWANDTE CHEMIE INT’L EDITION 7546 (2006) (co-author).
  • Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration, 5 CRYSTAL GROWTH DESIGN 1013 (2005) (co-author).
  • Solvent-Drop Grinding: Green Polymorph Control of Cocrystallisation, CHEMICAL COMM. 890 (2004) (co-author).




"Next Generation Lawyer," in the category of Intellectual Property: Patents: Litigation, The Legal 500, 2021


back to top